Sort
10,766 grants matching “checkpoint inhibitor”
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$69,246Lily Yang · Emory University · R01 · FY2024 · CA
Stroma penetrating and immune modulating nanoparticles for image-guided therapy of pancreatic cancer
$69,246Lily Yang · Emory University · R01 · FY2024 · CA
Detection of Colorectal Cancer Adaptive Mutability May Justify Combination of Targeted- and Immune-Therapies
$68,770Timothy J Yeatman · University Of Utah · R21 · FY2021 · CA
Translational & Clinical Research (TACR) Program
$68,762Muneesh Tewari · University Of Michigan At Ann Arbor · P30 · FY2021 · CA
Translational & Clinical Research (TACR) Program
$68,762Muneesh Tewari · University Of Michigan At Ann Arbor · P30 · FY2020 · CA
Translational & Clinical Research (TACR) Program
$68,760Muneesh Tewari · University Of Michigan At Ann Arbor · P30 · FY2019 · CA
Production of Interferon Gamma by Regulatory T Cells Mediates Response to Immunotherapy
$68,562Angela Marie Gocher-Demske · University Of Pittsburgh At Pittsburgh · F32 · FY2021 · CA
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
$68,499Zihai Li · Ohio State University · R01 · FY2024 · CA
Centers for Cancer Systems Therapeutics (CaST)
$68,255Andrea Califano · Columbia University Health Sciences · U54 · FY2019 · CA
Clinical Protocol and Data Management
$68,172Grzegorz Stanislaw Nowakowski · Mayo Clinic Rochester · P30 · FY2024 · CA
Impact of heme catabolism on triple negative breast cancer metastasis via immune-suppression
$68,010Michelle M Williams · University Of Colorado Denver · F32 · FY2020 · CA
Advancing the translatability of mouse models for cancer immunotherapy
$67,968Rosemary J Akhurst · University Of California, San Francisco · R01 · FY2019 · CA
Population Modeling of Bladder Cancer Detection and Control
$67,752Thomas Trikalinos · Brown University · U01 · FY2025 · CA
Investigating conserved mechanisms that orchestrate the prophase to metaphase transition during meiosis I
$67,582Ian Wolff · Cornell University · F32 · FY2022 · HD
Targeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma
$67,582Christina Anna Elizabeth Von Roemeling · University Of Florida · F32 · FY2022 · CA
Translational & Clinical Research (TACR) Program
$67,505Muneesh Tewari · University Of Michigan At Ann Arbor · P30 · FY2022 · CA
Project 1: Delta immune Ecology of NSCLC
$67,476Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2025 · CA
Administrative Supplement to Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
$67,446Hasan Korkaya · Wayne State University · R01 · FY2024 · CA
Role of the Gut Microbiota in Regulating Responses to anti-PD-1 Cancer Immunotherapy
$67,446Joon Seok Park · Harvard Medical School · F32 · FY2020 · CA
Clinical Research Program
$66,766Matthew I Milowsky · Univ Of North Carolina Chapel Hill · P30 · FY2025 · CA
Project 3 Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint Blockade
$66,643Timothy An-Thy Chan · Cleveland Clinic Lerner Com-Cwru · U54 · FY2023 · CA
Pro-tumor functions of neutrophils in squamous cell lung cancer
$66,555Trudy Gale Oliver · University Of Utah · R01 · FY2022 · CA
A Pharmacogenomic Approach Using Precision Models of Hepatocellular Carcinoma to Identify Novel Therapeutics
$66,390Alexander Rialdi · Icahn School Of Medicine At Mount Sinai · F32 · FY2021 · CA
Pilot Project Developing immune checkpoint controlled -release biomaterials for cancer immunology
$66,389Anil Shanker · Meharry Medical College · U54 · FY2023 · CA
Targeted STAT3 inhibition impairs MDSC mobilization and recruitment in glioblastoma
$65,994Christina Anna Elizabeth Von Roemeling · University Of Florida · F32 · FY2021 · CA